MedTrace Logo

Mucositis and Infection Reduction With Liquid Probiotics in Children With Cancer

NCT03785938 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-12-24

No results posted yet for this study

Summary

The aim of this study is to evaluate the feasibility of an randomised-controlled trial to investigate the efficacy of liquid probiotics to prevent or reduce mucositis and infection in children diagnosed with cancer who are undergoing treatment with regimes likely to cause mucositis.

Conditions

  • Pediatric Cancer

Interventions

DIETARY_SUPPLEMENT

Probiotic

Liquid probiotic supplied by the company Symprove

OTHER

Placebo

Placebo made of maltdextrin. Will be similar in taste and consistency

Sponsors & Collaborators

  • University of Leeds

    lead OTHER

Principal Investigators

  • Hadeel Hassan, MBCHB MSc · University of Leeds

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-20
Primary Completion
2019-07-20
Completion
2019-08-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03785938 on ClinicalTrials.gov